Myriad Genetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYGN and other ETFs, options, and stocks.About MYGN
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A.
MYGN Key Statistics
Stock Snapshot
Myriad Genetics(MYGN) stock is priced at $4.74, giving the company a market capitalization of 443.23M. It carries a P/E multiple of -1.21.
As of 2026-03-18, Myriad Genetics(MYGN) stock has fluctuated between $4.38 and $5.05. The current price stands at $4.74, placing the stock +8.2% above today's low and -6.1% off the high.
Myriad Genetics(MYGN) shares are trading with a volume of 752.12K, against a daily average of 2.04M.
In the last year, Myriad Genetics(MYGN) shares hit a 52-week high of $10.30 and a 52-week low of $3.76.
In the last year, Myriad Genetics(MYGN) shares hit a 52-week high of $10.30 and a 52-week low of $3.76.
MYGN News
Myriad Genetics (MYGN) announced that the FDA has approved the MyChoice CDx Test as the companion diagnostic for Zejula, a PARP inhibitor from GSK, for patients...
Analyst ratings
54%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.